Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 96
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neuroscience ; 334: 134-147, 2016 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-27497709

RESUMEN

Several lines of evidence indicate group III metabotropic glutamate receptors (mGluRs) have systemic anti-hyperalgesic effects. We hypothesized this could occur through modulation of TRP channels on nociceptors. This study used a multifaceted approach to examine the interaction between group III mGluRs (mGluR8) and transient receptor potential ankyrin 1 (TRPA1) on cutaneous nociceptors in rats. Ca2+ imaging studies demonstrated co-localization and functional coupling of TRPA1 and mGluR8, since 1µM (S)-3,4-dicarboxyphenylglycine (DCPG) (mGluR8 agonist) significantly reduced Ca2+ mobilization produced by 30µM mustard oil (MO), a TRPA1 agonist. Behavioral studies demonstrated that 10mM MO produced mechanical hypersensitivity when topically applied to the hind paw, significantly decreasing paw withdrawal threshold (PWT) from 15g to 6g. However, administration of 30µM DCPG prior to 10mM MO reversed this hypersensitivity such that PWT was not significantly different from baseline. At the single-fiber level, compared to vehicle, 30µM MO significantly increased nociceptor activity and decreased mechanical threshold. However, 30µM DCPG reversed both of these MO-induced effects. Furthermore, DCPG significantly reduced the number of MO-induced mechanically sensitive fibers. Inhibition of protein kinase A (PKA) using Rp-cyclic 3',5'-hydrogen phosphorothioate adenosine triethylammonium salt (RpCAMPS) (PKA inhibitor, 1 and 10µM) significantly reduced MO-induced Ca2+ mobilization. Taken together, these results show that group III mGluRs negatively modulate TRPA1 activity on cutaneous nociceptors. Furthermore, it is likely that this modulation occurs intracellularly at the level of the cAMP/PKA pathway. This study demonstrates that group III agonists may be effective in the treatment of mechanical hypersensitivity which can develop as a result of inflammation, nerve injury, chemotherapy and other disease states.


Asunto(s)
Receptores de Glutamato Metabotrópico/metabolismo , Canales Catiónicos TRPC/metabolismo , Animales , Benzoatos/farmacología , Calcio/metabolismo , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Agonistas de Aminoácidos Excitadores/farmacología , Glicina/análogos & derivados , Glicina/farmacología , Prueba de Histocompatibilidad , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/metabolismo , Masculino , Planta de la Mostaza , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Aceites de Plantas , Proteínas Quinasas/farmacología , Ratas Sprague-Dawley , Receptores de Glutamato Metabotrópico/agonistas , Canal Catiónico TRPA1
2.
Neuroscience ; 217: 130-9, 2012 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-22609935

RESUMEN

Several lines of evidence indicate group III metabotropic glutamate receptors (mGluRs) have systemic anti-hyperalgesic effects. We hypothesized this could occur through modulation of transient receptor potential vanilloid 1 (TRPV1) receptors on nociceptors. To address this question we performed anatomical studies to determine if group III mGluRs were expressed on cutaneous axons and if they co-localized with TRPV1. Immunostaining at the electron microscopic level demonstrated that 22% of unmyelinated axons labeled for mGluR8. Immunostaining at the light microscopic level in lumbar dorsal root ganglia (DRG) demonstrated that 80% and 28% of neurons labeled for mGluR8 or TRPV1, respectively. Of those neurons labeled for mGluR8, 25% labeled for TRPV1; of those labeled for TRPV1, 71% labeled for mGluR8. In behavior studies intraplantar injection of the group III mGluR agonist, L-(+)-2-amino-4-phosphonobutyric acid (L-AP-4: 0.1, 1.0, and 10.0 µM) had no effect on paw withdrawal latency (PWL) to heat in naïve rats but administration of 10 µM L-AP-4 prior to 0.05% capsaicin (CAP), significantly attenuated CAP-induced lifting/licking and reduced flinching behavior. The L-AP-4 effect was specific since administration of a group III antagonist α-methyl-3-methyl-4-phosphonophenylglycine (UBP1112) (100µM) blocked the L-AP-4 effect on CAP, resulting in behaviors similar to CAP alone. Intraplantar injection of UBP1112 alone did not result in nociceptive behaviors, indicating group III mGluRs are not tonically active. Finally, the anti-hyperalgesic effect of group III in this paradigm was local and not systemic since intraplantar administration of L-AP-4 in one hind paw did not attenuate nociceptive behaviors following CAP injection in the contralateral hind paw. Adenyl cyclase/cyclic AMP/PKA may be the second messenger pathway linking these two receptor families because intraplantar injection of forskolin (FSK, 10 µM) reduced PWL to heat and L-AP-4 reversed this FSK effect. Taken together, these results suggest group III mGluRs can negatively modulate TRPV1 through inhibition of adenyl cyclase and downstream intracellular activity, blocking TRPV1-induced activation of nociceptors.


Asunto(s)
Conducta Animal/fisiología , Ganglios Espinales/metabolismo , Nociceptores/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Canales Catiónicos TRPV/metabolismo , Animales , Conducta Animal/efectos de los fármacos , Colforsina/farmacología , Agonistas de Aminoácidos Excitadores/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Ganglios Espinales/efectos de los fármacos , Masculino , Dimensión del Dolor/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/fisiología , Receptores de Glutamato Metabotrópico/agonistas , Receptores de Glutamato Metabotrópico/antagonistas & inhibidores
3.
Neuroscience ; 154(3): 1054-66, 2008 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-18514429

RESUMEN

Mechanisms underlying cold hypersensitivity in neuropathic states are unclear. Recent data indicate both transient receptor potential (TRP) M8 and TRPA1 play a role. In relation to TRPA1, there are reported increases in mRNA. However, it is unknown whether TRPA1 mRNA is translated into functional receptors, whether these receptors are found on peripheral nociceptors and what population of primary afferents expresses the receptors. The present study provides several lines of evidence that TRPA1 receptors are expressed on intact primary sensory neurons and contribute to cold hypersensitivity following spinal nerve ligation (SNL). Immunohistochemical studies show that expression of TRPA1 is significantly increased in the ipsilateral compared with the contralateral L4 dorsal root ganglion (DRG). Using mustard oil (MO, selective TRPA1 agonist), Ca(2+) imaging demonstrates an increase in the percentage of MO-sensitive L4 DRG cells in SNL compared with sham and naive rats. The magnitude of the Ca(2+) response evoked by MO is also significantly larger in SNL compared with sham and naive rats. Behavioral studies demonstrate that SNL results in increased nocifensive behaviors to mechanical and cold stimulation that is not seen in sham or naive rats. Behavioral responses in sham rats are no different from naive rats. In vitro single fiber recordings demonstrate Adelta-fibers (intact L4 axons) in the nerve-injured hind paw have conduction velocities no different from naive rats. In contrast, compared with naive rats, mechanical thresholds of the Adelta-fibers in SNL rats are significantly decreased, the proportion of cold-sensitive and MO-sensitive Adelta-fibers is significantly increased and the response magnitude of Adelta-fibers to MO is significantly increased. MO-induced activity in Adelta-fibers is significantly reduced by Ruthenium Red (TRPA1 receptor antagonist). These results demonstrate that TRPA1 is expressed on peripheral nociceptors, and they are up-regulated on intact Adelta-fibers following nerve injury, contributing to cold hypersensitivity.


Asunto(s)
Canales de Calcio/biosíntesis , Canales de Calcio/fisiología , Frío , Fibras Nerviosas Mielínicas/fisiología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Acetona/farmacología , Animales , Ancirinas , Axones/efectos de los fármacos , Axones/ultraestructura , Conducta/efectos de los fármacos , Calcio/metabolismo , Tamaño de la Célula , Células Cultivadas , Citosol/efectos de los fármacos , Citosol/metabolismo , Electrofisiología , Ganglios Espinales/citología , Ganglios Espinales/efectos de los fármacos , Inmunohistoquímica , Masculino , Microscopía Electrónica , Planta de la Mostaza , Neuronas/efectos de los fármacos , Dimensión del Dolor/efectos de los fármacos , Sistema Nervioso Periférico/citología , Sistema Nervioso Periférico/efectos de los fármacos , Enfermedades del Sistema Nervioso Periférico/patología , Enfermedades del Sistema Nervioso Periférico/psicología , Estimulación Física , Aceites de Plantas/farmacología , Ratas , Ratas Sprague-Dawley , Canal Catiónico TRPA1 , Canales Catiónicos TRPC
4.
Neuroscience ; 154(2): 754-66, 2008 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-18487022

RESUMEN

Several lines of evidence indicate that Group II metabotropic glutamate receptor (mGluR) activation can depress sensory transmission. We have reported the expression of Group II mGluRs on unmyelinated axons, many of which were presumed to be nociceptors, in the rat digital nerve [Carlton SM, Hargett GL, Coggeshall RE (2001b) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969]. The goals of the present study are to further our understanding of Group II modulation of nociceptor processing in the periphery, documenting behavioral changes using inflammatory models and documenting, for the first time, cutaneous single fiber activity following exposure to a Group II agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) and antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, LY). The data indicate that peripheral Group II mGluR activation does not depress nociceptive behaviors or nociceptor fiber responses in the non-sensitized state (i.e. following brief nociceptive mechanical or thermal stimulation) but can depress these responses when nociceptors are sensitized by exposure to formalin or inflammatory soup. Group II mGluR agonist-induced inhibition can be blocked by a selective Group II antagonist. Peripheral Group II mGluR-induced inhibition evoked in these studies occurs through activation of local receptors and not through spinal or supraspinal mechanisms. The data indicate that administration of selective Group II agonists may be potent therapeutic agents for prevention of peripheral sensitization and for treatment of inflammatory pain.


Asunto(s)
Agonistas de Aminoácidos Excitadores/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Inflamación/tratamiento farmacológico , Inflamación/patología , Dolor/tratamiento farmacológico , Dolor/etiología , Receptores de Glutamato Metabotrópico/agonistas , Receptores de Glutamato Metabotrópico/antagonistas & inhibidores , Aminoácidos/farmacología , Animales , Conducta Animal/efectos de los fármacos , Ciclopentanos/farmacología , Calor , Inflamación/complicaciones , Masculino , Fibras Nerviosas/efectos de los fármacos , Nociceptores/efectos de los fármacos , Nervios Periféricos/efectos de los fármacos , Estimulación Física , Ratas , Ratas Sprague-Dawley , Piel/inervación , Xantenos/farmacología
5.
Neuroscience ; 150(1): 182-93, 2007 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-17945425

RESUMEN

Cold hypersensitivity is a common sensory abnormality accompanying peripheral neuropathies and is difficult to treat. Progress has been made in understanding peripheral mechanisms underlying neuropathic pain but little is known concerning peripheral mechanisms of cold hypersensitivity. The aim of this study was to analyze the contribution of uninjured primary afferents to the cold hypersensitivity that develops in neuropathic rats. Rats with a lumbar 5 (L5) and L6 spinal nerve ligation (SNL, Chung model) but not sham, developed mechanical allodynia, evidenced by decreased paw withdrawal thresholds and increased magnitude of response to von Frey stimulation. Cold hypersensitivity also developed in SNL but not sham rats, evidenced by enhanced nociceptive behaviors induced by placement on a cold plate (6 degrees C) or application of icilin (a transient receptor potential M8 (TRPM8)/transient receptor potential A1 (TRPA1) receptor agonist) to nerve-injured hind paws. Single fiber recordings demonstrated that the mean conduction velocities of intact L4 cutaneous A delta- and C-fibers were not different between naive and SNL rats; however, mechanical thresholds of the A delta- but not the C-fibers were significantly decreased in SNL compared with naive. There was a higher prevalence of C-mechanoheat-cold (CMHC) fibers in SNL compared with naive, but the overall percentage of cold-sensitive C-fibers was not significantly increased compared with naive. This was in contrast to the numerous changes in A delta-fibers: the percentage of L4 cold sensitive A delta-, but not C-fibers, was significantly increased, the percentage of L4 icilin-sensitive A delta-, but not C-fibers, was significantly increased, the icilin-induced activity of L4 A delta-, but not C-fibers, was significantly increased. Icilin-induced activity was blocked by the TRPA1 antagonist Ruthenium Red. The results indicate plasticity in both A delta- and C-uninjured fibers, but A delta fibers appear to provide a major contribution to cold hypersensitivity in neuropathic rats.


Asunto(s)
Frío/efectos adversos , Hiperalgesia/etiología , Hiperalgesia/patología , Fibras Nerviosas/fisiología , Plasticidad Neuronal/fisiología , Enfermedades del Sistema Nervioso Periférico/complicaciones , Potenciales de Acción/fisiología , Análisis de Varianza , Animales , Calcio/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Ganglios Espinales/patología , Masculino , Conducción Nerviosa/fisiología , Neuronas Aferentes/efectos de los fármacos , Neuronas Aferentes/fisiología , Umbral del Dolor/fisiología , Enfermedades del Sistema Nervioso Periférico/patología , Estimulación Física , Pirimidinonas/farmacología , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción , Estadísticas no Paramétricas
6.
Pain ; 124(1-2): 34-49, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16650579

RESUMEN

Several lines of evidence support an important role for somatostatin receptors (SSTRs) in pain modulation. The therapeutic use of established SSTR peptide agonists for this indication is limited by their broad range of effects, need for intrathecal delivery, and short half-life. Therefore, the goal of the present study was to investigate the analgesic effect of SCR007, a new, highly selective SSTR2 non-peptide agonist. Behavioral studies demonstrated that paw withdrawal latencies to heat were significantly increased following intraplantar SCR007. Furthermore, both intraperitoneal and intraplantar injection of SCR007 significantly reduced formalin- and capsaicin-induced flinching and lifting/licking nociceptive behaviors. Recordings from nociceptors using an in vitro glabrous skin-nerve preparation showed that SCR007 reduced heat responses in a dose-dependent fashion, bradykinin-induced excitation, heat sensitization and capsaicin-induced excitation. In both the behavioral and single fiber studies, the SCR007 effects were reversed by the SSTR antagonist cyclo-somatostatin, demonstrating receptor specificity. In the single fiber studies, the opioid antagonist naloxone did not reverse SCR007-induced anti-nociception suggesting that SCR007 did not exert its effects through activation of opioid receptors. Analysis of cAMP/protein kinase A (PKA) involvement demonstrated that SCR007 prevented forskolin- and Sp-8-Br-cAMPS (a PKA activator)-induced heat sensitization, supporting the hypothesis that SCR007-induced inhibition could involve a down-regulation of the cAMP/PKA pathway. These data provide several lines of evidence that the non-peptide imidazolidinedione SSTR2 agonist SCR007 is a promising anti-nociceptive and analgesic agent for the treatment of pain of peripheral and/or central origin.


Asunto(s)
Analgésicos/uso terapéutico , Dolor/tratamiento farmacológico , Somatostatina/agonistas , 8-Bromo Monofosfato de Adenosina Cíclica/análogos & derivados , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/efectos de la radiación , Análisis de Varianza , Animales , Conducta Animal , Unión Competitiva/efectos de los fármacos , Unión Competitiva/fisiología , Bradiquinina/farmacología , Capsaicina/efectos adversos , Colforsina/farmacología , Interacciones Farmacológicas , Formaldehído/efectos adversos , Calor/efectos adversos , Imidazolidinas/uso terapéutico , Técnicas In Vitro , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Masculino , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas/efectos de la radiación , Dolor/inducido químicamente , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Piel/efectos de los fármacos , Piel/inervación , Tionucleótidos/farmacología
7.
Neuroscience ; 137(3): 999-1013, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16330152

RESUMEN

This study investigates contributions of peripheral kainate receptors to acute nociception and persistent inflammatory pain in rat. Immunohistochemical analysis of kainate receptor expression using antibodies recognizing glutamate receptor subunits 5, 6, and 7 demonstrates that 28% of unmyelinated axons in normal digital nerve are positively labeled. Following intraplantar injection of complete Freund's adjuvant, a significant increase in glutamate receptor subunits 5, 6, and 7-labeled axons occurs at 2 days (40%), but not 7 (31%) or 14 days (28%) post-complete Freund's adjuvant. In behavioral studies, we confirm an increased mechanical sensitivity in complete Freund's adjuvant-injected hind paws. Furthermore, activation of kainate receptors following intraplantar injection of 1.0 mM kainate in normal animals results in a mechanical sensitivity similar to that observed in inflamed animals. A 1.0 mM kainate injection into inflamed hind paws further enhances the mechanical sensitivity. Injection of the non-N-methyl-D-aspartate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (0.1 mM) reverses complete Freund's adjuvant-induced mechanical sensitivity through a local effect. In single unit recordings from nociceptors in a glabrous skin-nerve preparation, mechanical sensitization is present in inflamed skin evidenced by a decrease in mechanical threshold and an increase in discharge rate during a suprathreshold, constant force stimulus. Thermal sensitization is also present evidenced by a decrease in heat threshold. There is a dose-dependent increase in kainate-induced nociceptor activity in both normal and inflamed skin but the kainate required to induce activation is reduced in inflamed skin. Although proportions of kainate-activated nociceptors are the same in normal and inflamed skin, the kainate-induced mean discharge rate is significantly enhanced in inflamed skin. Exposure of normal and inflamed nociceptors to 0.3 mM kainate sensitizes fibers to re-application of kainate and heat. This sensitization is blocked in the presence of 6-cyano-7-nitroquinoxaline-2,3-dione or the glutamate receptor subunit 5 selective antagonist 3S,4aR,6S,8aR-6-[4-carboxy-phenyl] methyl-1,2,3,4,4a,5,6,7,8,8a-deca-hydroisoquinoline-3-carboxylic acid. The data indicate that peripheral kainate receptors not only play an important role in normal nociception but also contribute to mechanical sensitivity and heat sensitization accompanying inflammatory pain.


Asunto(s)
Dermatitis/fisiopatología , Agonistas de Aminoácidos Excitadores/farmacología , Ácido Kaínico/farmacología , Nociceptores/efectos de los fármacos , Piel/efectos de los fármacos , Animales , Axones/metabolismo , Conducta Animal/efectos de los fármacos , Péptido Relacionado con Gen de Calcitonina/metabolismo , Relación Dosis-Respuesta a Droga , Electrofisiología , Habituación Psicofisiológica/efectos de los fármacos , Calor , Masculino , Dolor/etiología , Dolor/fisiopatología , Nervios Periféricos/metabolismo , Estimulación Física , Ratas , Ratas Sprague-Dawley , Piel/inervación , Estimulación Química
8.
Pain ; 111(1-2): 151-61, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15327819

RESUMEN

The responses of antidromically identified spinothalamic tract (STT) neurons to mechanical and thermal stimuli were compared in anesthetized normal and neuropathic monkeys before and after administration of a GluR5 kainate receptor antagonist (LY382884) into the spinal cord dorsal horn through a microdialysis fiber. Peripheral neuropathy was induced by tight ligation of the L7 spinal nerve 13-15 days prior to the experiment. STT neurons recorded in the animals with neuropathy showed increased responsiveness to weak mechanical stimuli and to heating and cooling of the skin compared to STT cells in normal animals. In both normal and the neuropathic monkeys the responses of the STT neurons to mechanical and thermal stimuli were attenuated by LY382884 application in a concentration-dependent manner. Intraspinal application of LY382884 in the neuropathic animals led to a potent reduction of those responses of the STT neurons that were aggravated by the peripheral neuropathy (weak mechanical, heat and innocuous cooling stimuli). These results suggest that kainate receptors are involved in synaptic activation of STT cells in the normal state and may also play an important role in pathological pain states such as peripheral neuropathy in primates. Kainate receptor antagonists could thus be useful for the treatment of certain forms of allodynia and hyperalgesia.


Asunto(s)
Isoquinolinas/farmacología , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Receptores de Ácido Kaínico/antagonistas & inhibidores , Tractos Espinotalámicos/citología , Animales , Frío , Modelos Animales de Enfermedad , Calor , Hiperalgesia/tratamiento farmacológico , Macaca fascicularis , Masculino , Neuronas/efectos de los fármacos , Estimulación Física
9.
Neuroscience ; 120(2): 499-508, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12890519

RESUMEN

Our hypothesis is that peripheral somatostatin (SRIF) has a role in counter-irritation-induced analgesia. Our paradigm involves the reduction of nociceptive behaviors produced by primary noxious stimuli (formalin or complete Freund's adjuvant [CFA] in the rat hind paw) by a counter-irritating stimulus (capsaicin [CAP] in the tail or muzzle). Activation of peripheral SRIF receptors is key since an SRIF receptor antagonist cyclo-somatostatin (c-SOM) and SRIF antibodies in the hind paw attenuate the counter-irritation-induced analgesia of both formalin and more persistent CFA nociception. Specificity of c-SOM is shown by reversal of its effects with octreotide, a SRIF analog. Injection of formalin in one hind paw and c-SOM in the other does not reduce the counter-irritation analgesia demonstrating local action of the c-SOM. Approximately 33% of peripheral sensory axons contain SRIF, which could release the peptide to activate SRIF receptors on cutaneous axons. Intraplantar naloxone has no effect on the counter-irritation analgesia indicating that SRIF is not activating opioid receptors. These results indicate that in addition to the classic central descending noxious inhibitory control systems that underlie counter-irritation-induced analgesia, there is a peripheral contribution arising from activation of SRIF receptors. Identifying a peripheral contribution of SRIF to mechanisms of counter-irritation analgesia offers opportunities for peripheral therapy.


Asunto(s)
Analgesia , Dolor/metabolismo , Nervios Periféricos/efectos de los fármacos , Receptores de Somatostatina/fisiología , Animales , Conducta Animal , Capsaicina/efectos adversos , Recuento de Células , Vías de Administración de Medicamentos/veterinaria , Interacciones Farmacológicas , Formaldehído , Adyuvante de Freund , Masculino , Microscopía Electrónica/instrumentación , Microscopía Electrónica/métodos , Dolor/inducido químicamente , Dolor/fisiopatología , Dolor/prevención & control , Dimensión del Dolor/efectos de los fármacos , Péptidos/inmunología , Péptidos/metabolismo , Péptidos Cíclicos/farmacología , Nervios Periféricos/ultraestructura , Estimulación Física/métodos , Ratas , Ratas Sprague-Dawley , Receptores de Somatostatina/antagonistas & inhibidores , Receptores de Somatostatina/inmunología , Factores de Tiempo
10.
Neuroscience ; 118(2): 547-62, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12699789

RESUMEN

The present study investigates the contribution of peripheral N-methyl-D-aspartate (NMDA) receptors to acute nociception and persistent inflammatory pain in the rat. Immunohistochemical localization of the NMDA receptor one (NMDAR1) subunit demonstrates that 47% of unmyelinated axons in the normal digital nerve are positively labeled. In concert with the overall progression of inflammation following injection of complete Freund's adjuvant (CFA) in the hind paw, a significant increase in the proportion of NMDAR1-labeled unmyelinated digital axons occurs at 2 and 7, but not 14 days following hind-paw inflammation. In behavioral studies, we confirm an increased mechanical sensitivity in CFA-injected hind paws. Furthermore, activation of NMDA receptors following intraplantar NMDA (1.0 mM) in normal animals results in a mechanical sensitivity similar to that observed in inflamed animals. Conversely, a low concentration of NMDA (0.5 mM) that has little affect on mechanical thresholds in normal animals produces a significant increase in mechanical sensitivity in the inflamed state. CFA-induced mechanical sensitivity involves NMDA-receptor activation demonstrated by the observation that injection of MK-801 alone into the inflamed hind paw returns mechanical sensitivity to normal (pre-inflammation) levels. In single-unit studies, there is a dose-dependent increase in NMDA-induced nociceptor activity in both normal and inflamed skin, but the amount of NMDA required to induce activation is reduced in inflamed skin. In addition, NMDA-induced discharge rates and percentage of NMDA-activated nociceptors are significantly increased in inflamed compared with normal skin, and this activation can be blocked by co-administration of MK-801. Exposure of nociceptors in normal skin to 1 mM NMDA sensitizes the units to reapplication of NMDA and to heat. Nociceptors that demonstrate sensitization to heat in persistent inflammation show an enhanced sensitization when exposed to exogenous NMDA. Thus, peripheral NMDA receptors not only play an important role in modulating the responses of nociceptors in normal skin, but their upregulation and activation on peripheral nociceptors contributes significantly to the mechanical sensitivity and heat sensitization that accompanies persistent inflammation.


Asunto(s)
Agonistas de Aminoácidos Excitadores/farmacología , N-Metilaspartato/farmacología , Nociceptores/efectos de los fármacos , Potenciales de Acción , Animales , Axones/patología , Axones/ultraestructura , Maleato de Dizocilpina/farmacología , Relación Dosis-Respuesta a Droga , Electrofisiología , Antagonistas de Aminoácidos Excitadores/farmacología , Adyuvante de Freund/envenenamiento , Miembro Posterior/patología , Miembro Posterior/fisiopatología , Calor/efectos adversos , Técnicas In Vitro , Inflamación/inducido químicamente , Inflamación/metabolismo , Masculino , Nociceptores/metabolismo , Nociceptores/fisiopatología , Dimensión del Dolor , Estimulación Física , Ratas , Ratas Sprague-Dawley , Umbral Sensorial , Piel/inervación , Piel/patología , Piel/fisiopatología , Piel/ultraestructura , Estimulación Química , Factores de Tiempo
11.
Curr Opin Pharmacol ; 1(1): 52-6, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11712535

RESUMEN

Glutamate receptors (GluRs) are localized in the periphery on nociceptive primary afferent terminals. Studies in animal models of pain demonstrate that peripheral glutamate is involved in nociceptive transmission in the normal and the inflamed state and that modulation of peripheral GluRs reduces pain behaviors and nociceptor activity. These data provide strong motivation to develop new pharmacological agents that will target peripheral GluRs, offering novel approaches to treatment of pain of peripheral origin.


Asunto(s)
Aminoácidos Excitadores/fisiología , Sistema Nervioso Periférico/fisiología , Animales , Humanos , Inflamación/fisiopatología , Ligandos , Neuronas Aferentes/efectos de los fármacos , Sistema Nervioso Periférico/fisiopatología , Receptores de Glutamato/fisiología
12.
Neuroscience ; 105(4): 957-69, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11530234

RESUMEN

The goal of the present study is to determine the relationship of metabotropic glutamate receptors 2/3 (mGluR2/3) to dorsal root ganglion cells, peripheral primary afferent fibers in digital nerves and central primary afferent fibers in the spinal cord. We demonstrate that approximately 40% of L4 and L5 dorsal root ganglion cells contain mGluR2/3-like immunoreactivity. These mGluR2/3-positive cells are small in diameter (23 microm) and 76% stain for the isolectin Griffonia simplicifolia (I-B4), while 67% of I-B4 cells have mGluR2/3-like immunoreactivity. Electron microscopic analyses of mGluR2/3-like immunoreactivity in axons in digital nerves indicate that 32% of unmyelinated and 28% of myelinated axons are labeled. In the lumbar dorsal horn, mGluR2/3-like immunoreactivity is localized preferentially in lamina IIi with lighter staining in laminae III and IV. The dense mGluR2/3-like immunoreactivity in lamina IIi is consistent with the localization of these receptors in I-B4-labeled dorsal root ganglion cells. Elimination of primary afferent input following unilateral dorsal rhizotomies significantly decreases the mGluR2/3-like immunoreactivity density in the dorsal horn although some residual staining does remain, suggesting that many but not all of these receptors are located on primary afferent processes. The finding that mGluR2/3s are located on peripheral sensory axons suggests that they are involved in peripheral sensory transduction and can modulate transmission of sensory input before it reaches the spinal cord. This offers the possibility of altering sensory input, particularly noxious input, at a site that would avoid CNS side effects. Since many but not all of these receptors are located on primary afferent terminals, these receptors may also influence primary afferent transmission in the dorsal horn through presynaptic mechanisms and glutamatergic transmission in general through both presynaptic and postsynaptic mechanisms. Since these receptors are concentrated in lamina IIi and also largely co-localized with I-B4, they may have considerable influence on nociceptive processing by what are considered to be non-peptidergic primary afferent neurons.


Asunto(s)
Axones/metabolismo , Neuronas Aferentes/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Animales , Péptido Relacionado con Gen de Calcitonina/metabolismo , Ganglios Espinales/metabolismo , Inmunohistoquímica , Lectinas/farmacocinética , Masculino , Microscopía Electrónica , Fibras Nerviosas/metabolismo , Sistema Nervioso/metabolismo , Ratas , Ratas Sprague-Dawley , Rizotomía , Médula Espinal/metabolismo , Coloración y Etiquetado , Distribución Tisular , Dedos del Pie/inervación
13.
Brain Res ; 913(1): 18-26, 2001 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-11532243

RESUMEN

Several lines of evidence indicate that Group I metabotropic glutamate (mGlu) 1alpha receptors are involved in the processing of nociceptive information in the spinal cord. The goals of the present study are to document the role of mGlu1alpha receptors in peripheral nociception. To accomplish this we investigate the presence of mGlu1alpha receptors on peripheral primary afferent fibers and determine the behavioral effects of (S)-3,5-dihydroxyphenylglycine (S-DHPG), which is an mGlu1/5 receptor agonist and (RS)-1-aminoindan-1, 5-dicarboxylic acid (AIDA), a selective mGluR1alpha antagonist, on mechanical and thermal sensitivity and formalin-induced nociceptive behaviors. The anatomical studies at the electron microscopic level demonstrate that 32.4+/-2.9% of the unmyelinated axons and 21.6+/-4.7% of the myelinated axons are positively immunostained for mGlu1alpha receptors. Intraplantar injection of 0.1 or 1 mM S-DHPG results in a significant increase in mechanical sensitivity that persists for more than 60 min and this effect is blocked by co-injection of S-DHPG with 1 mM AIDA. Intraplantar injection of 40 microM AIDA+2% formalin significantly attenuates phase 2 lifting/licking and flinching behavior and this AIDA-induced effect is blocked with co-injection of 1 microM S-DHPG. In behavioral tests, intraplantar S-DHPG (0.1, 1.0, 10 mM) does not change tail flick latencies or paw withdrawal latencies to heat stimulation. These data indicate that mGlu1alpha receptors are present on peripheral cutaneous axons and activation of peripheral mGlu1alpha receptors contributes to mechanical allodynia and inflammatory pain but not thermal hyperalgesia.


Asunto(s)
Ganglios Espinales/metabolismo , Fibras Nerviosas/metabolismo , Neuronas Aferentes/metabolismo , Nociceptores/metabolismo , Dolor/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Sensación Térmica/fisiología , Animales , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas/fisiología , Agonistas de Aminoácidos Excitadores/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/ultraestructura , Glicina/análogos & derivados , Glicina/farmacología , Inmunohistoquímica , Indanos/farmacología , Inflamación/metabolismo , Masculino , Microscopía Electrónica , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas/ultraestructura , Neuronas Aferentes/efectos de los fármacos , Neuronas Aferentes/ultraestructura , Nociceptores/efectos de los fármacos , Nociceptores/ultraestructura , Dimensión del Dolor/efectos de los fármacos , Estimulación Física , Ratas , Ratas Sprague-Dawley , Receptores de Glutamato Metabotrópico/efectos de los fármacos , Resorcinoles/farmacología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Piel/inervación , Sensación Térmica/efectos de los fármacos
14.
Neurosci Lett ; 310(1): 53-6, 2001 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-11524156

RESUMEN

The vanilloid receptor-1 (VR1) is activated by capsaicin, heat and protons and is localized on primary sensory neurons. The present study investigates whether VR1 increases in the inflamed hindpaw thereby contributing to the peripheral sensitization and heat hyperalgesia that characterizes the inflamed state. Forty-eight hours after intraplantar injection of Complete Freund's Adjuvant into one hindpaw, there is a significant increase in the proportion of VR1-labeled unmyelinated axons in digital nerves in the inflamed (32.8 +/- 5.9%) compared to normal (17.1 +/- 2.6%) hindpaws (t-test, P<0.01). A few, small diameter myelinated axons are labeled in normal and inflamed rats with no change in percentages following inflammation. The data suggest that an increase in number of unmyelinated sensory axons expressing VR1 may be one mechanism underlying peripheral sensitization of nociceptors in inflammation.


Asunto(s)
Inflamación/metabolismo , Nervios Periféricos/metabolismo , Receptores de Droga/biosíntesis , Animales , Axones/patología , Axones/ultraestructura , Tamaño de la Célula , Adyuvante de Freund , Hiperalgesia/metabolismo , Hiperalgesia/patología , Inmunohistoquímica , Inflamación/inducido químicamente , Inflamación/patología , Masculino , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas/metabolismo , Neuronas Aferentes/patología , Neuronas Aferentes/ultraestructura , Nervios Periféricos/patología , Ratas , Ratas Sprague-Dawley , Dedos del Pie/inervación
15.
J Reprod Med ; 46(6): 601-5, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11441688

RESUMEN

BACKGROUND: Placenta accreta involves abnormal adherence of the placenta to the myometrium. Placenta increta and percreta are defined by the degree of trophoblastic penetration of the myometrium. These conditions are rarely observed in the first trimester; placenta increta and percreta are exceptionally infrequent. CASE: A woman had a uterine perforation after suction curettage for fetal death at 11 weeks' gestation, requiring hysterectomy for control of a profuse hemorrhage. Histopathologic examination of the uterus revealed placenta increta involving the lower uterine segment and placenta percreta at the site of uterine perforation. CONCLUSION: This is the first report of placenta percreta associated with uterine perforation during therapy for first-trimester fetal death.


Asunto(s)
Muerte Fetal , Placenta Accreta/etiología , Perforación Uterina/etiología , Legrado por Aspiración/efectos adversos , Adulto , Femenino , Humanos , Histerectomía , Placenta Accreta/patología , Placenta Accreta/cirugía , Hemorragia Posoperatoria/etiología , Embarazo , Primer Trimestre del Embarazo
16.
J Neurosci ; 21(11): 4042-9, 2001 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-11356891

RESUMEN

The peptide somatostatin [somatotropin release-inhibiting factor (SRIF)] is widely distributed in the body and exerts a variety of hormonal and neural actions. Several lines of evidence indicate that SRIF is important in nociceptive processing: (1) it is localized in a subset of small-diameter dorsal root ganglion cells; (2) activation of SRIF receptors results in inhibition of both nociceptive behaviors in animals and acute and chronic pain in humans; (3) SRIF inhibits dorsal horn neuronal activity; and (4) SRIF reduces responses of joint mechanoreceptors to noxious rotation of the knee joint. The goal of the present study is to show that cutaneous nociceptors are under the tonic inhibitory control of SRIF. This is accomplished using behavioral and electrophysiological paradigms. In a dose-dependent manner, intraplantar injection of the SRIF receptor antagonist cyclo-somatostatin (c-SOM) results in nociceptive behaviors in normal animals and enhancement of nociceptive behaviors in formalin-injected animals, and these actions can be blocked when c-SOM is coapplied with three different SRIF agonists. Furthermore, intraplantar injection of SRIF antiserum also results in nociceptive behaviors. Electrophysiological recordings using an in vitro glabrous skin-nerve preparation show increased nociceptor activity in response to c-SOM, and this increase is blocked by the same three SRIF agonists. Parallel behavioral and electrophysiological studies using the opioid antagonist naloxone demonstrate that endogenous opioids do not maintain a tonic inhibitory control over peripheral nociceptors, nor does opioid receptor antagonism influence peripheral SRIF effects on nociceptors. These findings demonstrate that SRIF receptors maintain a tonic inhibitory control over peripheral nociceptors, and this may contribute to mechanisms that control the excitability of these terminals.


Asunto(s)
Nociceptores/metabolismo , Sistema Nervioso Periférico/metabolismo , Receptores de Somatostatina/metabolismo , Piel/inervación , Somatostatina/análogos & derivados , Animales , Conducta Animal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Calor , Sueros Inmunes/administración & dosificación , Técnicas In Vitro , Inyecciones Subcutáneas , Masculino , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Conducción Nerviosa/efectos de los fármacos , Conducción Nerviosa/fisiología , Nociceptores/citología , Nociceptores/efectos de los fármacos , Octreótido/administración & dosificación , Dimensión del Dolor/efectos de los fármacos , Péptidos Cíclicos/administración & dosificación , Sistema Nervioso Periférico/citología , Sistema Nervioso Periférico/efectos de los fármacos , Estimulación Física , Ratas , Ratas Sprague-Dawley , Receptores de Somatostatina/agonistas , Receptores de Somatostatina/antagonistas & inhibidores , Somatostatina/administración & dosificación , Somatostatina/antagonistas & inhibidores , Estimulación Química
17.
Nat Neurosci ; 4(4): 417-23, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11276233

RESUMEN

The metabotropic glutamate receptors (mGluRs) are found throughout the central nervous system, where they modulate neuronal excitability and synaptic transmission. Here we report the presence of phospholipase C-coupled group I mGluRs (mGluR1 and mGluR5) outside the central nervous system on peripheral unmyelinated sensory afferents. Given their localization on predominantly nociceptive afferents, we investigated whether these receptors modulate nociceptive signaling, and found that agonist-induced activation of peripheral group I mGluRs leads to increased sensitivity to noxious heat, a phenomenon termed thermal hyperalgesia. Furthermore, group I mGluR antagonists not only prevent, but also attenuate established formalin-induced pain. Taken together, these results suggest that peripheral mGluRs mediate a component of hyperalgesia and may be therapeutically targeted to prevent and treat inflammatory pain.


Asunto(s)
Neuronas Aferentes/metabolismo , Dolor/fisiopatología , Receptores de Glutamato Metabotrópico/metabolismo , Valina/análogos & derivados , Animales , Cromonas/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Glicina/análogos & derivados , Glicina/farmacología , Miembro Posterior , Calor , Inmunohistoquímica , Inflamación/fisiopatología , Masculino , Ratones , Ratones Endogámicos C57BL , Neuronas Aferentes/efectos de los fármacos , Neuronas Aferentes/ultraestructura , Dolor/inducido químicamente , Dimensión del Dolor , Piridinas/farmacología , Receptores de Glutamato Metabotrópico/antagonistas & inhibidores , Valina/farmacología
18.
Pain ; 89(2-3): 187-98, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11166475

RESUMEN

Anatomical studies demonstrate the presence of glutamate receptors on unmyelinated axons in peripheral cutaneous nerves. Pharmacological studies show that intraplantar injection of glutamate or glutamate agonists in the glabrous skin results in nociceptive behaviors. The present study describes a novel in vitro skin-nerve preparation using the glabrous skin from the rat hindpaw. In the first series of experiments, recordings were obtained from 141 fibers that responded to a strong mechanical search stimulus. Based on their conduction velocity they were classified as C (27%), A delta (28%) and A beta (45%) fibers. The C and A delta fibers typically exhibited sustained firing during suprathreshold mechanical stimuli whereas both rapidly (66%) and slowly (34%) adapting responses were obtained from A beta fibers. Noxious heat excited 46% of the C fibers but only 12% of the A delta units. In another series of experiments application of an ascending series of glutamate concentrations (10, 100, 300, and 1000 microM) to A delta (n=14) and C (n=19) nociceptors resulted in a significant excitation of 43% (6/14) A delta fibers and 68% (13/19) C fibers. At these concentrations, there was no excitation of A beta units (n=13). Superfusion of the receptive fields of either mechanoheat-sensitive A (AMH, n=10) or C fibers (CMH, n=12) for 2 min with 300 microM glutamate resulted in sensitization of 90% (9/10) AMH and 92% (11/12) CMH fibers to subsequent thermal stimulation. This was evidenced by a significant (1) decrease in thermal threshold for activation, (2) increase in discharge rate, and (3) increase in peak instantaneous frequencies during the second heat trial. Glutamate-induced sensitization to heat occurred in the absence of either a glutamate-induced excitation or an initial heat response. Exposure of A delta or C fibers to glutamate did not result in a decrease in von Frey thresholds. These data provide a physiological basis for the nociceptive behaviors that arise following intraplantar injection of glutamate or glutamate agonists. Furthermore, demonstration of glutamate-induced excitation and heat sensitization of nociceptors indicates that local or topical administration of glutamate receptor antagonists may have therapeutic potential for the treatment of pain.


Asunto(s)
Ácido Glutámico/farmacología , Nociceptores/efectos de los fármacos , Piel/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Calor , Masculino , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas Mielínicas/efectos de los fármacos , Neurofisiología , Umbral del Dolor/efectos de los fármacos , Estimulación Física , Ratas , Ratas Sprague-Dawley , Piel/inervación
19.
Neurosci Lett ; 283(2): 149-52, 2000 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-10739897

RESUMEN

Recent observations suggest that glutamate is important in sensory transduction in the periphery, contributing to peripheral sensitization of nociceptors and the hyperalgesia that accompanies inflammation. This study examined the presence of ionotropic glutamate receptors N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methylisoxazolone-4-propionic acid (AMPA) and kainate (KA) in normal human hairy skin (n=6) using immunohistochemistry at the electron microscopic level. Analysis of labeled axons at the dermal-epidermal junction demonstrated that 26. 9+/-2, 19.5+/-3 and 18.5+/-1% of the axons analyzed were labeled for subunits of the NMDA, AMPA or KA receptors, respectively. An occasional Schwann cell process was labeled for either NMDA or KA receptors. The findings support the hypothesis that glutamate and its ionotropic receptors may play a role in the periphery in sensory processing in humans.


Asunto(s)
Axones/metabolismo , Receptores de Glutamato/análisis , Piel/inervación , Axones/ultraestructura , Dermis/inervación , Epidermis/inervación , Cabello , Humanos , Receptores AMPA/análisis , Receptores de Ácido Kaínico/análisis , Receptores de N-Metil-D-Aspartato/análisis
20.
Neuroreport ; 11(3): 497-502, 2000 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-10718302

RESUMEN

The present study demonstrates that following A and/or C fiber stimulation of the sciatic nerve, glutamate levels increase significantly in the hindpaw extracellular space. In hindpaw dialysate, electrical stimulation (5 min) of the sciatic nerve at 2x, 20x, 50x or 200x threshold current required to produce a muscle twitch resulted in peak glutamate increases of 120.8 +/- 9%, 134.3 +/- 5%, 153.9 +/- 10% and 150.5 +/- 5% of basal levels, respectively. Application of 1% capsaicin to the sciatic nerve (10 min) to selectively activate C fibers resulted in a peak glutamate increase of 130.8 +/- 8% of basal levels. Aspartate levels did not change significantly in either paradigm. These data indicate that low and high intensity stimulation can result in peripheral release of glutamate, providing a major source of ligand for the glutamate receptors localized on peripheral primary afferents.


Asunto(s)
Espacio Extracelular/metabolismo , Ácido Glutámico/metabolismo , Miembro Posterior , Nervio Ciático/fisiología , Aminoácidos/metabolismo , Animales , Capsaicina/farmacología , Estimulación Eléctrica , Masculino , Microdiálisis , Concentración Osmolar , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...